Estimation of HIV-1 DNA level interfering with reliability of HIV-1 RNA quantification performed on dried blood spots collected from successfully treated patients

Journal of Clinical Microbiology

Volumn 54, Issue 6, 2016, Pages 1641-1643

  Zida, Sylvie ^a,b   Tuaillon, Edouard ^b   Barro, Makoura ^c   Franchard, Arnaud Kwimatouo Lekpa ^a   Kagoné, Thérèse ^a   Nacro, Boubacar ^c   Ouedraogo, Abdoul Salam ^d   Bolloré, Karine ^b   Sanosyan, Armen ^b   Plantier, Jean Christophe ^e   Meda, Nicolas ^a   Sangaré, Lassana ^d   Rouzioux, Christine ^f   Rouet, François ^g   Kania, Dramane ^a  

^a CENTRE MURAZ   (Burkina Faso)

^b UNIV MONTPELLIER   (France)

^c CHU Souro Sanou   (Burkina Faso)

^d CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^e ROUEN UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONTROLLED STUDY; DNA DETERMINATION; DRIED BLOOD SPOT TESTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; RNA EXTRACTION; VIREMIA; VIRUS LOAD; BLOOD; DESICCATION; DIAGNOSTIC ERROR; DRUG MONITORING; FALSE POSITIVE RESULT; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PROCEDURES; SPECIMEN HANDLING; VIROLOGY;

DESICCATION; DIAGNOSTIC ERRORS; DNA, VIRAL; DRUG MONITORING; FALSE POSITIVE REACTIONS; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; SPECIMEN HANDLING; VIRAL LOAD;

EID: 84970004127     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03372-15     Document Type: Article

References (11)

1. World Health Organization. 2013. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. World Health Org anization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727-eng.pdf?ua-1.
2. Monleau M Aghokeng AF Eymard-Duvernay S Dagnra A Kania D Ngo-Giang-Huong N Touré- Kane C Truong LXT Chaix M-L Delaporte E Ayouba A Peeters M ANRS 12235 Study Group. 2014. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretrovi ral therapy in Africa and Asia. J Clin Microbiol, 52, 578-586,http://dx.doi.org/10.1128/JCM.02860-13
3. Viljoen J, Gampini S, Danaviah S, Valéa D, Pillay S, Kania D, Méda N, Newell ML , Van de Perre P, Rouet F, World Health Organization/ANRS 1289 Kesho Bora Study Group. 2010. Dried blood spot HIV-1 RNA quantification using open real-time systems in South Africa and Burkina Faso. J Acquir Immune Defic Syndr 55:290-298. http://dx.doi.org/10.1097/QAI.0b013e3181edaaf5.
4. Prach LM, Puren A, Lippman SA, Carmona S, Stephenson S, Cutler E, Barnhart S, Liegler T. 2015. Design and implementati on of an external quality assessment program for HIV viral load measurements using dried blood spots. J Clin Microbiol 53:964-966. http://dx.doi.org/10.1128/JCM.02698-14.
5. Smit PW, Sollis KA, Fiscus S , Ford N, Vitoria M, Essajee S, Barnett D, Cheng B, Crowe SM, Denny T, Landay A, Stevens W, Habiyambere V, Perriens JH, Peeling RW. 2014. Systematic review of the use of dried blood spots for monito ring HIV viral load and for early infant diagnosis. PLoS One 9:e86461. http://dx.doi.org/10.1371/journal.pone.0086461.
6. World Health Organization. 2014. Technical and operational considerations for implementing HIV viral load testing. World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/arv/viral-load-testing -technical-update/en/.
7. Fajardo E, Metcalf CA, Chaillet P, Aleixo L, Pannus P, Panunzi I, Triviño L, Ellman T, Likaka A, Mwenda R. 2014. Prospective evaluation of diagnostic accuracy of dried blood spots from finger prick samples for determination of HIV-1 load with the NucliSENS Easy-Q HIV-1 version 2.0 assay in Malawi. J Clin Microbiol 52:1343-1351. http://dx.doi.org/10.1128/JCM.03519-13.
8. Yapo V, d'Aquin Toni T, Desmonde S, Amani-Bosse C, Oga M, Lenaud S, Menana H, Timité-Konan M, Leroy V, Rouzioux C. 2013. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study. J Virol Methods 193:439-445. http://dx.doi.org/10.1016/j.jviromet.2013.07.011.
9. Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamp s D, Plantier J-C. 2014. Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency. J Clin Microbiol 52 :2740-2741. http://dx.doi.org/10.1128/JCM.00962-14.
10. Costenaro P, Lundin R, Petrara MR, Penazzato M, Massavon W, Kizito S, Nabachwa SM, Nannyonga Musoke M, Namisi C, Morelli E, B ilardi D, Mazza A, Zanchetta M, Giaquinto C, De Rossi A. 2014. Viral load detection using dried blood spots in a cohort of HIV-1-infected children in Uganda: Correlations with clinical and immunological criteria for treatment fail ure. J Clin Microbiol 52:2665-2667. http://dx.doi.org/10.1128/JCM.00961-14.
11. Sawadogo S, Shiningavamwe A, Chang J, Maher AD, Zhang G, Yang C, Gaeb E, Kaura H, Ellenberger D, Lowrance DW. 2014. Limited utility of dried-blood-and plasma spot-based screening for antiretroviral treatment failure with Cobas Ampliprep/TaqMan HIV-1 version 2.0. J Clin Microbiol 52:3878-3883. http://dx.doi.org/10.1128/ JCM.02063-14.